- Home
- Publications
- Publication Search
- Publication Details
Title
Biology and Treatment of Richter Transformation
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-28
DOI
10.3389/fonc.2022.829983
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter’s Transformation
- (2022) Valentín Ortiz-Maldonado et al. Frontiers in Oncology
- ROR1 targeting with the antibody drug-conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models
- (2021) Tiziana Vaisitti et al. BLOOD
- BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma
- (2021) Warren Fiskus et al. LEUKEMIA
- Synergistic efficacy of dual PI3K-d/g inhibitor Duvelisib with Bcl2 inhibitor Venetoclax in Richter's Syndrome PDX models
- (2021) Andrea Iannello et al. BLOOD
- B Cell Receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter Transformation
- (2021) Supriya Chakraborty et al. BLOOD
- Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial
- (2021) Martin Hutchings et al. JOURNAL OF CLINICAL ONCOLOGY
- Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
- (2021) Yucai Wang et al. Blood Cancer Journal
- Outcomes of Richter’s transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database
- (2021) Radowan Elnair et al. ANNALS OF HEMATOLOGY
- Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target
- (2021) Clare Gould et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chronic lymphocytic leukaemia and Richter's transformation: multimodal review and new imaging paradigms
- (2021) E. Musanhu et al. CLINICAL RADIOLOGY
- The complex karyotype landscape in chronic lymphocytic leukemia allows to refine the risk of Richter syndrome transformation
- (2021) Andrea Visentin et al. HAEMATOLOGICA
- Artificial intelligence strategy integrating morphologic and architectural biomarkers provides robust diagnostic accuracy for disease progression in Chronic Lymphocytic Leukemia
- (2021) Siba El Hussein et al. JOURNAL OF PATHOLOGY
- CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness
- (2021) Richard Lewis et al. LEUKEMIA
- A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
- (2021) Ying Zhang et al. Frontiers in Oncology
- Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome
- (2021) Alex F. Herrera et al. Blood Advances
- Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter’s transformation
- (2021) Oscar B. Lahoud et al. Blood Advances
- Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition
- (2021) Thomas E Lew et al. Blood Advances
- Venetoclax, Obinutuzumab and Atezolizumab (PD-L1 Checkpoint Inhibitor) for Treatment for Patients with Richter Transformation
- (2021) Nitin Jain et al. BLOOD
- Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome
- (2021) Matthew S. Davids et al. BLOOD
- Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1–2 study
- (2021) Toby A Eyre et al. Lancet Haematology
- Feasibility and efficacy of CD19-targeted CAR-T cells with concurrent ibrutinib for CLL after ibrutinib failure
- (2020) Jordan Gauthier et al. BLOOD
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial
- (2020) Jeff P Sharman et al. LANCET
- Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
- (2020) O. Al-Sawaf et al. LEUKEMIA
- Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)
- (2020) Pau Abrisqueta et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome
- (2020) Adam S. Kittai et al. Blood Advances
- Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib
- (2020) Paul J. Hampel et al. Blood Advances
- Genomic and transcriptomic correlates of Richter's transformation in Chronic Lymphocytic Leukemia.
- (2020) Jenny Klintman et al. BLOOD
- 2-[18F]-FDG PET/CT Role in Detecting Richter Transformation of Chronic Lymphocytic Leukemia and Predicting Overall Survival
- (2020) Domenico Albano et al. Clinical Lymphoma Myeloma & Leukemia
- U-RT1 – A new model for Richter transformation
- (2020) Teresa Schmid et al. NEOPLASIA
- Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1
- (2020) Vivien Kohlhaas et al. BLOOD
- Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
- (2019) Anas Younes et al. Lancet Haematology
- Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway
- (2019) Andrea Lenartova et al. Cancer Epidemiology
- Eµ-TCL1xMyc: a novel mouse model for concurrent CLL and B-cell lymphoma
- (2019) Fabienne Lucas et al. CLINICAL CANCER RESEARCH
- PHASE I CLINICAL TRIAL OF CD19-TARGETED 19-28Z/4-1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION
- (2019) C.L. Batlevi et al. HEMATOLOGICAL ONCOLOGY
- Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
- (2019) Tait D. Shanafelt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
- (2019) Kirsten Fischer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
- (2019) Joshua W.D. Tobin et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of Baseline Total Metabolic Tumor Volume Measured on FDG PET in Patients With Richter Syndrome
- (2019) Clémence Pontoizeau et al. CLINICAL NUCLEAR MEDICINE
- PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT)
- (2018) Rong He et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome
- (2018) Andrea Visentin et al. BRITISH JOURNAL OF HAEMATOLOGY
- PD-1 is highly expressed by neoplastic B-cells in Richter transformation
- (2018) Amir Behdad et al. BRITISH JOURNAL OF HAEMATOLOGY
- Novel Richter's syndrome xenograft models to study genetic architecture, biology and therapy responses
- (2018) Tiziana Vaisitti et al. CANCER RESEARCH
- Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
- (2018) Michael Y. Choi et al. Cell Stem Cell
- The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation
- (2018) Sean D. Reiff et al. Cancer Discovery
- Tumor Antigen Escape from CAR T-cell Therapy
- (2018) Robbie G. Majzner et al. Cancer Discovery
- Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
- (2018) Carol Moreno et al. LANCET ONCOLOGY
- Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
- (2018) Jennifer A. Woyach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib
- (2017) Cameron J. Turtle et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
- (2017) Matthew S. Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity and tolerability of the Bruton's tyrosine kinase (Btk) inhibitor PCI-32765 in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Interim results of a phase Ib/II study.
- (2017) J. C. Byrd et al. JOURNAL OF CLINICAL ONCOLOGY
- Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma
- (2016) Rose Lou Marie C. Agbay et al. AMERICAN JOURNAL OF HEMATOLOGY
- Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience
- (2016) A. R. Mato et al. BLOOD
- NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome
- (2016) Toby A. Eyre et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review
- (2016) Elizabeth J Soilleux et al. HISTOPATHOLOGY
- An 18F-FDG-PET maximum standardized uptake value > 10 represents a novel valid marker for discerning Richter’s Syndrome
- (2016) Anne-Sophie Michallet et al. LEUKEMIA & LYMPHOMA
- Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma
- (2016) Peter Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison tode novoHodgkin lymphoma
- (2015) Sameer A. Parikh et al. AMERICAN JOURNAL OF HEMATOLOGY
- Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8
- (2015) M. Gounari et al. BLOOD
- A phase 2 study of idelalisib plus rituximab in treatment-naive older patients with chronic lymphocytic leukemia
- (2015) S. M. O'Brien et al. BLOOD
- The efficacy of ibrutinib in the treatment of Richter syndrome
- (2015) M. Tsang et al. BLOOD
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1
- (2015) Michael Y. Choi et al. Clinical Lymphoma Myeloma & Leukemia
- XIV. The pathology of transformation of indolent B cell lymphomas
- (2015) Randy D. Gascoyne HEMATOLOGICAL ONCOLOGY
- Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
- (2015) F R Mauro et al. LEUKEMIA
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
- (2015) Jan A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
- (2015) Idit Sagiv-Barfi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- Ibrutinib has some activity in Richter’s syndrome
- (2015) S Giri et al. Blood Cancer Journal
- Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation
- (2014) Petra Langerbeins et al. AMERICAN JOURNAL OF HEMATOLOGY
- Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia
- (2014) L. Falchi et al. BLOOD
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
- (2013) E. Chigrinova et al. BLOOD
- Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients
- (2013) Sameer A. Parikh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Therapy in Aggressive Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome
- (2013) Apostolia M. Tsimberidou et al. Clinical Lymphoma Myeloma & Leukemia
- Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
- (2013) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches
- (2013) Lei Ding et al. NATURE
- Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome
- (2012) Davide Rossi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
- (2012) Kate Cwynarski et al. JOURNAL OF CLINICAL ONCOLOGY
- NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome
- (2012) N Villamor et al. LEUKEMIA
- MGA, a suppressor ofMYC, is recurrently inactivated in high risk chronic lymphocytic leukemia
- (2012) Lorenzo De Paoli et al. LEUKEMIA & LYMPHOMA
- Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
- (2011) D. Rossi et al. BLOOD
- The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
- (2011) D. Rossi et al. BLOOD
- Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature
- (2011) Bruno Bockorny et al. BRITISH JOURNAL OF HAEMATOLOGY
- Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior
- (2010) E. Gine et al. HAEMATOLOGICA
- Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
- (2010) William G. Wierda et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome
- (2009) D. Rossi et al. CLINICAL CANCER RESEARCH
- Phase I-II Study of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Combination Therapy in Patients With Richter's Syndrome or Fludarabine-Refractory Chronic Lymphocytic Leukemia
- (2008) Apostolia M. Tsimberidou et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started